Amylyx Pharmaceuticals Inc banner

Amylyx Pharmaceuticals Inc
NASDAQ:AMLX

Watchlist Manager
Amylyx Pharmaceuticals Inc Logo
Amylyx Pharmaceuticals Inc
NASDAQ:AMLX
Watchlist
Price: 14.35 USD 3.24% Market Closed
Market Cap: $1.6B

Profitability Summary

Amylyx Pharmaceuticals Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Amylyx Pharmaceuticals Inc

Margins Comparison
Amylyx Pharmaceuticals Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Amylyx Pharmaceuticals Inc
NASDAQ:AMLX
1.6B USD
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
901.8B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
587.8B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
248.4B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
233B GBP
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
299B USD
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
235.8B CHF
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
237.1B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
162.3B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
124.3B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Amylyx Pharmaceuticals Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Amylyx Pharmaceuticals Inc
NASDAQ:AMLX
1.6B USD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
901.8B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
587.8B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
248.4B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
233B GBP
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
299B USD
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
235.8B CHF
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
237.1B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
162.3B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
124.3B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Amylyx Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett